2-METHOXY-5-NITROBENZOTRIFLUORIDE | CAS:654-76-2

We serve 2-METHOXY-5-NITROBENZOTRIFLUORIDE CAS:654-76-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-METHOXY-5-NITROBENZOTRIFLUORIDE

Chemical Name: 2-METHOXY-5-NITROBENZOTRIFLUORIDE
CAS.NO:654-76-2
Synonyms:1-Methoxy-4-nitro-2-(trifluoromethyl)benzene;
Molecular Formula: C8H6F3NO3
Molecular Weight:221.13300
 
Physical and Chemical Properties:
Density:1.392 g/cm3
Melting point:79-81 °C(lit.)
Boiling point:267.2ºC at 760 mmHg
Flash point:115.4ºC
Index of Refraction:1.517
 
Specification:
Appearance:White to light yellow crystal powder
Purity:≥99.0%
 
Packing: 20kg/carton  oraccording to customer request
Storage:Stable at room temperature in closed containers under normal storage and handling conditions.
Application:  Applicationd as dyes, pesticides, pharmaceutical intermediates



Contact us for information like 2-METHOXY-5-NITROBENZOTRIFLUORIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Methoxy-4-nitro-2-(trifluoromethyl)benzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Methoxy-4-nitro-2-(trifluoromethyl)benzene Use and application,2-METHOXY-5-NITROBENZOTRIFLUORIDE technical grade,usp/ep/jp grade.


Related News: Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs.N-Cbz-D-Serine manufacturer Both patients were being treated in isolation units at a Manila hospital.tert-butyl 4-(2-ethoxycarbonyl-1-benzofuran-5-yl)piperazine-1-carboxylate supplier Both patients were being treated in isolation units at a Manila hospital.3-methylpyridine-2-carbonitrile vendor Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry.